Rhumbline Advisers Frequency Therapeutics, Inc. Transaction History

Rhumbline Advisers

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.33 - $0.48 $349 - $507	1,058 New	1,058 $0
Q2 2022 Aug 11, 2022	SELL	$1.03 - $2.03 $41,996 - $82,769	-40,773 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.7 - $5.72 $5,006 - $16,845	-2,945 Reduced 6.74%	40,773 $86,000
Q4 2021 Feb 10, 2022	SELL	$4.95 - $7.11 $5,544 - $7,963	-1,120 Reduced 2.5%	43,718 $224,000
Q3 2021 Nov 12, 2021	BUY	$6.96 - $9.25 $7,495 - $9,962	1,077 Added 2.46%	44,838 $317,000
Q2 2021 Aug 05, 2021	BUY	$8.05 - $11.61 $105,100 - $151,580	13,056 Added 42.52%	43,761 $436,000
Q1 2021 May 06, 2021	SELL	$7.99 - $55.01 $14,238 - $98,027	-1,782 Reduced 5.49%	30,705 $292,000
Q4 2020 Feb 10, 2021	BUY	$18.65 - $40.0 $31,406 - $67,360	1,684 Added 5.47%	32,487 $1.15 Million
Q3 2020 Nov 12, 2020	SELL	$17.76 - $24.96 $102,777 - $144,443	-5,787 Reduced 15.82%	30,803 $592,000
Q2 2020 Aug 13, 2020	BUY	$14.65 - $24.9 $536,043 - $911,091	36,590 New	36,590 $851,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.